@article {10.3844/ajidsp.2006.173.179,
article_type = {journal},
title = {Coronary Heart Disease (CHD) Risk Factors and Metabolic Syndrome in HIV-Positive Drug Users in Miami},
author = {Baum, Marianna K and Rafie, Carlin and Lai, Shenghan and Xue, Lihua and Sales, Sabrina and Page, J. B. and Berkman, Ronald and Karas, Linden and Campa, Adriana},
volume = {2},
number = {3},
year = {2006},
month = {Sep},
pages = {173-179},
doi = {10.3844/ajidsp.2006.173.179},
url = {https://thescipub.com/abstract/ajidsp.2006.173.179},
abstract = {The frequency of coronary heart disease (CHD) is increasing among HIV seropositive persons. This phenomenon may be related to HIV disease itself, the use of antiretroviral medications and increased length of survival, or the synergism of these factors. In this study we have calculated the 10-year CHD risk estimate and the prevalence of metabolic syndrome in a cohort of 118 HIV seropositive chronic drug users, including those who are on HAART with or without protease inhibitors (PI). The results showed that the 10-year coronary heart disease risk among the HIV seropositive drug users was 4.8 ± 5.7, which is within the range of results published for other HIV infected cohorts. The 10-year CHD risk was significantly higher in men (5.9±6.1, p},
journal = {American Journal of Infectious Diseases},
publisher = {Science Publications}
}